Noticias | Notícies | News | UMH

Conferencias, I + D, Estudios, Update, Reconocimientos, Jornades, Summit, Esdeveniments, Investment, Master's degree, etc.


By: | Tags: , , , , , , , | Comments: 0 | March 1st, 2016

The last Thursday, February 25, Bartolomé Pérez Gálvez, professor in the Department of Clinical Medicine of the UMH, was awarded in “Gala Importantes of the Información” by the treatment of addictions in the public health system.
The psychiatrist from Alicante received the Provincial Auditorium of Alicante (ADDA) the award as “Importantes” in its 31st Edition.

Bartolomé Pérez Galvéz awarded the

source: Diario Información


What are the Importantes awarded” received Bartolomé Pérez Gálvez?

As every year, political representatives, business people, culture and society of the province of Alicante gathered in homage, from INFORMACIÓN, twelve professionals and entities that have distinguished themselves during the past 2015 by the performance of his professional activity and at the same time, they have contributed to society.

Bartolomé Pérez Gálvez on stage Importantes by Información

source: Diario Información

The professor of Psychiatry Bartolomé Pérez Gálvez collected the sculpture in the form of ‘I’ made in iron by the artist Adriano Carrillo as “Importante” for his role in the treatment of addictive behaviors in the University Hospital of Sant Joan d’Alacant (Spain). The “consellera” of Health System, Carmen Montón, was who handed the statuette for the month of March to the head of the Unit of Alcohology of the Hospital of Sant Joan d’Alacant (Spain), Bartolomé Pérez Gálvez, by the treatment of addictionsin the public health system.

Bartolomé Pérez Gálvez alcohology unit award UMH

source: Diario Información

More information about “the Importantes Ceremony” of Información in this link:

What is the goal of addiction treatment in the public health system by Bartolomé Pérez Gálvez?

The Hospital of Sant Joan d’Alacant (Spain) is considered one of the 22 centres chosen worldwide to be part of a clinical trial where it is testing the first drug against cocaine addiction.

This study is head by the National Institute on Drug Abuse (NIDA) of the United States, as well as by an israeli laboratory. The study 210 patients through 22 medical teams, 15 in the USA and 7 in Spain. The Hospital de Sant Joan d’Alacant (Spain), in particular the  Unit of Alcohology, is the only centre of Valencian Community which is integrated in the clinical trial. Other four hospitals in Barcelona and two in Madrid completed the Spanish contribution in it.

The main objective of this new drug is none other than the get through genetic manipulation one up, called butirilcolinesterasa (BChE), «more active to get the cocaine is metabolized more quickly and degrade a substance without psychotropic activity», explained the Dr. Bartolomé Pérez Gálvez, responsible of the Unit of Alcohology of the Hospital University Hospital of Sant Joan d’Alacant (Spain). The BChE is one of the most important enzymes in the metabolism of cocaine. New on getting through this drug “has more power to metabolize this substance and longevity in the blood.” The drug that is being tested in patients is administered on a weekly basis through intramuscular injection.

Dr. Bartolomé Pérez Gálvez and Addictive Behaviors Hospital Sant Joan de Alicante Spain

source: Diario Información

The main priority of the clinical trial, says Dr. Pérez Gálvez, the head of the Unit of Alcohology and professor in the Department of Clinical Medicine of the UMH, «is that till this moment there is no drug to treat cocaine addiction»», hence the prospects are hopeful. The study is currently in its phase II, “which is to seek the most effective dose of the drug”. The recruitment of patients in all centres of the country involved in the trial, which will be extended over the next three months, has already started.

The clinical study is composed by two parts, in addition to administering the medication, the patient has to undergo psychotherapy to treat his addiction. “Those involved in the trial have to come to query three times a week, so that we manage them medication, make them timely follow-up controls and participate in psychotherapy,” says Dr. Pérez Gálvez.

The criteria that it is following to recruit patients is having between 18 and 60 years , with cocaine dependence, with or without alcohol dependence, “and with sufficient motivation to complete the study, since there are very few places available,” concludes Dr. Bartolomé Pérez Gálvez.

More information about the treatment of addictions in the public health system by Bartolomé Pérez Gálvez in this link:

Leave a Reply